Germany’s ongoing pharmacy reform grants pharmacists the authority to administer a broader range of inactivated vaccines, such as tetanus and tick-borne encephalitis (FSME), alongside expanded blood-testing capabilities, according to announcements made by legislative bodies and pharmacy chambers.
Expanded Vaccine Offerings in German Pharmacies
Under the revised legislative framework passed by the Bundestag and Bundesrat, the scope of pharmacy-led immunizations extends beyond the seasonal influenza and COVID-19 vaccines previously permitted. Pharmacists can now offer additional inoculations, including protection against tetanus and FSME. Carsten Wohlfeil, managing director of the Saarland Chamber of Pharmacists (Apothekerkammer), stated that while many pharmacies already incorporate flu and corona vaccinations into their standard repertoires, immediate rollout of the new vaccines is unlikely. Wohlfeil noted that implementation will not occur this autumn, citing the necessity of completing specialized training and finalizing reimbursement negotiations with health insurance funds.
New Venous Blood Draws and Diagnostic Testing Rules
In addition to vaccinations, the reform authorizes pharmacies to perform venous blood draws for specific testing profiles. Currently, pharmacies are permitted to conduct various rapid tests using capillary blood from fingertips or swabs, which detect pathogens such as RSV, adenoviruses, influenza, and hepatitis C. Wohlfeil explained that customers must pay out-of-pocket for these pharmacy-administered tests, as health insurance providers do not cover them. While capillary blood draws also allow for checks on vitamin levels, iron, and thyroid hormones, they require costly specialized equipment. Although the legislation officially permits venous blood collection to establish risk profiles, Wohlfeil expressed skepticism about widespread adoption, emphasizing that specialized training is required and that pharmacists remain strictly prohibited from providing medical diagnoses or treatments, which stay exclusively within the purview of physicians.
Primary Care Physicians Raise Fragmentation Concerns
The expansion has drawn sharp criticism from general practitioners. Laila El-Masri, first chairwoman of the Saarland General Practitioners Association (Hausärzteverband), voiced strong concerns that the measures will further fragment primary care. El-Masri argued that establishing parallel structures and additional testing interfaces creates extra workloads for medical practices, noting that patients with abnormal test results from a pharmacy ultimately return to traditional doctors’ offices without the pharmacy having access to their complete medical history. The association also criticized pharmacy-based vaccinations, warning that management of potential vaccine side effects falls back onto local practices. Conversely, health economist David Matusiewicz argued that physicians’ opposition stems largely from professional self-interest and financial protectionism regarding budgets.
Keep reading